News

Use of the new 4-factor PCC, Beriplex

March 18th, 2025

As of mid-2024, Australia’s prothrombin complex concentrate (PCC) has been replaced by the new 4-factor PCC (Factors II, VII, IX, X) BERIPLEX P/N (international plasma). From February 2025, the...

2024 S&E Travel Grants Awarded

July 30th, 2024

This year THANZ awarded 6 S&E Travel Grants to the following members, who travelled to ISTH, Bangkok Rowena Brook, Emma Leitinger, Mitchell Moon, Caitlin Rice, Mark Schreuder and Trish Wise ...

2024 S&E Research Grants Awarded

July 30th, 2024

This year THANZ awarded S&E Research Grants to the following members mma Leitinger (Monash Health, Vic)Comparability of anti-Xa assessments using alternate calibration curves in patients...

IVIg use for Heparin induced thrombocytopenia (HIT) and Vaccine induced thrombotic thrombocytopenia (VITT)

February 29th, 2024

The National Blood Authority (NBA) has approved the inclusion of 5 indications of Heparin induced thrombocytopenia (HIT) in the Criteria for the clinical use of immunoglobulin in Australia (the C...

National COVID-19 Clinical Evidence Taskforce Guidelines

December 20th, 2023

The COVID-19 Vaccine Claims Scheme is being extended The COVID-19 Vaccine Claims Scheme is due to close on 17 April 2024. However, following the Mid-Year Economic and Fiscal Outlook (MYEFO) update pub...

ARES Study published

November 1st, 2023

The THANZ Anticoagulation Reversal and Events Study (ARES) Collaborative has recently published the results of the ARES Study. The paper is available here

2023 S&E Research Grants Awarded

July 11th, 2023

This year THANZ awarded S&E Research Grants to the following members Gabriella Pennings (ANZAC Research Institute/Sydney Local Health District)Mechanism/s of acute IL-1β release fro...

2023 S&E Travel Grants Awarded

June 14th, 2023

This year THANZ awarded 4 S&E Travel Grants to the following members Yvonne Kong who will travel to the University of Pavia, Italy Hannah Stevens will travel to the University of Ca...

National Statement for the Emergency Use of Group O Red Blood Cells

February 9th, 2023

The National Blood Authority is pleased to advise that the National Statement for the Emergency Use of Group O Red Blood Cells is now available on the National Blood Authority’s website...

Listen to Tim Brighton with Norman Swan on ABCs Coronacast

June 4th, 2021

You can listen to the ABCs Coronacast podcast from Thursday 3rd June, where THANZ member Tim Brighton speaks to host Norman Swan, here. Tim discusses risk factors, diagnosis, early detection, treatmen...

THANZ and ATAGI issue joint statement

May 25th, 2021

The THANZ and the Australian Technical Advisory Group on Immunisation (ATAGI) joint statement on Thrombosis with Thrombocytopenia Syndrome (TTS) and the use of COVID-19 Vaccine AstraZenecThe stateme...

VITT Multidisciplinary Guideline for Doctors

May 12th, 2021

The multidisciplinary VITT Communication Committee has developed and endorsed a VITT guideline for doctors. The guideline has also been endorsed by the THANZ VITT Advisory Committee and we are await...

IVIg available under national blood arrangements for VITT

April 29th, 2021

The National Blood Authority (NBA) has been monitoring the rapidly evolving situation with regard to vaccine-induced immune thrombotic thrombocytopenia (VITT), otherwise known as thrombosis with throm...

Suspected Vaccine Induced Prothrombotic Immune Thrombocytopenia (VIPIT): THANZ Advisory Statement (check for weekly updates)

April 2nd, 2021

The THANZ advisory statement on suspected vaccine induced prothrombotic immune thrombocytopenia (VIPIT) has been developed by the THANZ Vaccine Thrombocytopenia Working Group and i...

THANZ and HSANZ joint statement regarding the potential risk of thrombotic/bleeding events after COVID‐19 vaccination

April 2nd, 2021

The joint statement is available for members-only to download here.

ATAGI Statement for health care providers on suitability of COVID-19 vaccination in people with history of clotting conditions

March 25th, 2021

The full statement can be found here and the text is reproduced below. “Following the ATAGI statement of 19 March 2021 on the safety of the AstraZeneca COVID-19 vaccine,...

VTE Prevention: Implementationm guide

December 18th, 2020

Venous thromboembolism (VTE) remains among the 20 most frequently occurring hospital acquired complications [1]. The Australian Commission for Quality and Safety in Health Care (ACQSHC) has ...

NC19CET CPR Flow Charts

October 22nd, 2020

The National COVID-19 Clinical Evidence Taskforce has today issued guidance on CPR during the pandemic. Healthcare workers and trained first aid responders are being urged not to delay commencing card...

Preventing Another Clot

October 13th, 2020

The THANZ Education Committee has developed a patient information leaflet aimed at preventing another clot. The leaflet, which is being launched to coincide with World Thrombosis Day, 13th Octobe...

ISTH and THANZ COVID-19 and VTE Consensus Statement

July 16th, 2020

Emerging research has shown that patients who are hospitalized with COVID-19 have a high risk of developing a venous thromboembolism or VTE. A consensus statement has been issued by 7...

Clinical Trails Group Funding Available

January 9th, 2020

The THANZ Clinical Trials Group (CTG) is now accepting applications from THANZ members for grants to support T&H clinical trials. Each year there will be a maximum of $80,000 of grants available. ...

ACSQHC VTE Clinical Care Standard

October 11th, 2018

More information about the Clinical Care Standard, which is endorsed by THANZ, can be found here

New Patient Information Resources Published

August 1st, 2018

The THANZ Education Committee has launched a new series of on-line patient information leaflets covering Deep Vein Thrombosis Anti thrombin deficiency Factor V Leiden gene mutation Protein C deficien...

New Patient Information Resources Published

August 1st, 2018

NPAAC revised publications

July 19th, 2018

Five revised accreditation standards have been published and will come in to effect on 1 December 2018. For more information and to download the revised documents head to the NPAAC web siteP Requireme...

NPAAC revised publications

July 19th, 2018

Five revised accreditation standards have been published and will come in to effect on 1 December 2018. For more information and to download the revised documents head to the NPAAC web siteP Requireme...

ANZSBT Guidelines for the Administration of Blood Products

February 14th, 2018

The ANZSBT has released of the Guidelines for the Administration of Blood Products, 3rd Edition, 2018. These guidelines were developed by the Clinical Practice Improvement Committee (CP...

Patient Blood Management Guidelines

April 19th, 2017

The latest Patient Blood Management Guideline progress update is available from the National Blood Authority

Patient Blood Management Guidelines

April 19th, 2017

The latest Patient Blood Management Guideline progress update is available from the National Blood Authority

Call for Research Projects and Supervisors

May 25th, 2016

The following ASTH members have provided their research topics and availability for supervision. If you’re interested in adding your name to this list please contact asth@bigpond.com. Members can also...

The THANZ Story

May 25th, 2016

The THANZ was founded following discussions amongst coagulation enthusiasts led by Beng Chong, who had met together for the 1993 annual HSA meeting in Hobart. Until that time, clotters had consoled th...

Use of the new 4-factor PCC, Beriplex

2024 S&E Travel Grants Awarded

2024 S&E Research Grants Awarded

IVIg use for Heparin induced thrombocytopenia (HIT) and Vaccine induced thrombotic thrombocytopenia (VITT)

National COVID-19 Clinical Evidence Taskforce Guidelines

ARES Study published

2023 S&E Research Grants Awarded

2023 S&E Travel Grants Awarded

National Statement for the Emergency Use of Group O Red Blood Cells

Listen to Tim Brighton with Norman Swan on ABCs Coronacast

THANZ and ATAGI issue joint statement

VITT Multidisciplinary Guideline for Doctors

IVIg available under national blood arrangements for VITT

Suspected Vaccine Induced Prothrombotic Immune Thrombocytopenia (VIPIT): THANZ Advisory Statement (check for weekly updates)

THANZ and HSANZ joint statement regarding the potential risk of thrombotic/bleeding events after COVID‐19 vaccination

ATAGI Statement for health care providers on suitability of COVID-19 vaccination in people with history of clotting conditions

VTE Prevention: Implementationm guide

NC19CET CPR Flow Charts

Preventing Another Clot

ISTH and THANZ COVID-19 and VTE Consensus Statement

Clinical Trails Group Funding Available

ACSQHC VTE Clinical Care Standard

New Patient Information Resources Published

New Patient Information Resources Published

NPAAC revised publications

NPAAC revised publications

ANZSBT Guidelines for the Administration of Blood Products

Patient Blood Management Guidelines

Patient Blood Management Guidelines

Call for Research Projects and Supervisors

The THANZ Story

Our Sponsors

2024 Corporate Sponsor